Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

11.2K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
11.2K
Randomized Experiments01:13

Randomized Experiments

9.3K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
9.3K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

548
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
548
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

368
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
368
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.4K
Blinding01:11

Blinding

4.1K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
4.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Working years lost in people with epilepsy according to underlying aetiology: a population-based cohort study.

BMJ neurology open·2026
Same author

Societal costs for the closest family relatives of patients with brain disorders in Denmark: a population-based cohort study.

BMJ public health·2026
Same author

Changes in Genetic Contributions to ASD and ADHD by Year of Diagnosis.

JAMA psychiatry·2026
Same author

How deaths of despair shape life expectancy across sexes and regions in Sweden.

Scandinavian journal of public health·2026
Same author

The interaction between income and mental health conditions for subsequent physical health conditions: a nationwide Danish cohort study from 2000 to 2021.

The Lancet. Public health·2026
Same author

Individual- and population-level associations of mental disorders with intentional self-harm.

European psychiatry : the journal of the Association of European Psychiatrists·2026

Related Experiment Video

Updated: Apr 3, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.5K

Selecting the primary endpoint in a randomized clinical trial: The ARE method.

Oleguer Plana-Ripoll1, Guadalupe Gómez2

  • 1a Department of Public Health , Section of Epidemiology, Aarhus University , Aarhus , Denmark.

Journal of Biopharmaceutical Statistics
|September 25, 2015
PubMed
Summary

Choosing a primary endpoint for clinical trials is crucial. A new method quantifies the efficiency of using composite endpoints versus individual ones, aiding in trial design.

Keywords:
Asymptotic relative efficiencycomposite endpointcopulaslogrankrandomized clinical trial

More Related Videos

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.3K

Related Experiment Videos

Last Updated: Apr 3, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.5K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.5K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.3K

Area of Science:

  • Clinical Trials Methodology
  • Biostatistics
  • Medical Research Design

Background:

  • Selecting primary endpoints in randomized clinical trials is critical for study success.
  • Composite endpoints can offer increased statistical power but require careful construction.
  • Existing methods for evaluating composite endpoint efficiency may lack practicality.

Purpose of the Study:

  • To present the applicability of the Asymptotic Relative Efficiency (ARE) method for evaluating composite endpoint efficiency.
  • To provide a practical and objective tool for selecting optimal components for composite primary endpoints.
  • To extend the ARE method to accommodate various dependence structures between individual endpoints.

Main Methods:

  • Utilized the Asymptotic Relative Efficiency (ARE) method developed by Gómez and Lagakos (2013).
  • Calculated ARE based on component endpoint frequencies in the control group and relative treatment effects.
  • Applied the method to two real-world cardiovascular clinical trials.
  • Extended the methodology to incorporate different dependence structures between event times.

Main Results:

  • The ARE method serves as a practical tool for assessing the efficiency of potential composite endpoint components.
  • The choice between a composite and an individual endpoint recommendation is primarily influenced by endpoint frequencies and treatment effect magnitudes.
  • Different dependence structures between endpoints can impact the recommendation for composite endpoint usage.

Conclusions:

  • The Asymptotic Relative Efficiency (ARE) method is a valuable tool for optimizing primary endpoint selection in clinical trials.
  • The decision to use a composite endpoint hinges on the observed frequencies and relative treatment effects of its components.
  • This research provides a framework for objective evaluation of composite endpoints in cardiovascular and other clinical research areas.